Health care transactions:

• Representation of medical device manufacturer acquisitions of physician practices under MSO/PC model
• Representation of private equity firms in friendly MSO/PC models
• Representation of national purchaser of institutional pharmacies across the country
• Representation of non-profit hospice in affiliation with other non-profit hospices
• Representation of opioid treatment program in sale to private equity investor
• Representation of neonatology practice in sale to national practice
• Representation of dental practice in sale to national practice
• Representation of buyer in acquisition of inpatient rehabilitation facilities and long-term acute care hospitals
• Representation of buyer of pharmaceutical packaging business
• Representation of buyer of medical equipment business
• Representation of hospital system in spin-off of clinics to federally qualified health center
• Representation of hospital in connection with physician practice acquisitions
• Representation of private equity company in acquisition of medical equipment business

Represented hospitals in connection with:

• Acquisition of physician practices, including primary care, cardiology, physical medicine, radiation oncology, OB/GYN, and physical medicine
• Contracting with physicians and advanced practitioners for employment
• Contracting with physicians for hospital-based contracts
• Structuring of physician recruitment arrangements
• Guidance on fraud and abuse laws
• Use of telemedicine to expand care
• Compliance with HIPAA and data breaches

Represented clinical laboratories in connection with:

• Advising on the application of the Stark Law, Anti-Kickback Statute, and EKRA to common industry practices, including in-office phlebotomists, provisions of supplies to physician practices, leases with referring physicians, and non-monetary compensation
• Joint venture arrangements with other laboratory providers
• Privacy and security of laboratory test results, including investigations by the Office for Civil Rights, and patient access to lab test results
• Licensure, accreditation, and CLIA requirements

Represented manager of pain management clinics in connection with:

• Application of state pain management clinic laws to management service model
• Drafting of management service agreement
• Commenting on proposed rules of state board of pharmacy

Represented nursing facilities in connection with:

• Contracts with suppliers
• Financing transactions, including local counsel licensing opinions
• Advice on application of fraud and abuse laws to operational and ownership issues
• Use of telemedicine in nursing facilities

Represented drug treatment centers in connection with:

• Federal and state licensure and accreditation of drug treatment facilities
• SAMHSA regulations
• Practice of office based opioid treatment
• Disclosure of substance use disorder records under 42 CFR Part 2
• Use of telemedicine in drug treatment under federal and state law
• Application of EKRA to compensation of sales representatives

Represented pharmacies in connection with:

• DEA regulations and controlled substances registrations
• State licensing laws
• Acquisitions and sales of pharmacies

Represented medical device and pharmaceutical companies in connection with:

• Compliance policies and procedures
• Clinical research agreements
• Physician Payments Sunshine Act reporting obligations
• Contracting matters
• Analysis of proposed business arrangements for compliance with laws and AdvaMed Code

Represented digital health companies in connection with:

• Developing a women’s health treatment and pharmacy services platform
• Developing a behavioral and mental health therapy platform
• Developing a web-based health coaching telehealth business
• Developing a web-based physical therapy business
• Remote physiologic and therapeutic monitoring business models